Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000082

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 16, 2017
Accepted (ET)
Jun 20, 2017 · 1:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 16, 2017P1,000$0.052A21,233,349D
Common StockJun 16, 2017P1,000$0.0539A21,234,349D
Common StockJun 16, 2017P1,000$0.054A21,235,349D
Common StockJun 16, 2017P1,000$0.054A21,236,349D
Common StockJun 16, 2017P1,000$0.051A21,237,349D
Common StockJun 16, 2017P1,000$0.051A21,238,349D
Common StockJun 16, 2017P1,000$0.051A21,239,349D
Common StockJun 16, 2017P2,000$0.051A21,241,349D
Common StockJun 16, 2017P2,000$0.051A21,243,349D
Common StockJun 16, 2017P2,000$0.051A21,245,349D
Common StockJun 16, 2017P2,000$0.0525A21,247,349D
Common StockJun 16, 2017P2,000$0.0525A21,249,349D
Common StockJun 16, 2017P2,000$0.0525A21,251,349D
Common StockJun 16, 2017P2,000$0.0525A21,253,349D
Common StockJun 19, 2017P2,000$0.0519A21,255,349D
Common StockJun 19, 2017P1,000$0.0518A21,256,349D
Common StockJun 19, 2017P1,000$0.052A21,257,349D
Common StockJun 19, 2017P1,000$0.0507A21,258,349D
Common StockJun 19, 2017P1,000$0.0519A21,259,349D
Common StockJun 19, 2017P1,000$0.0517A21,260,349D
Common StockJun 19, 2017P1,000$0.0517A21,261,349D
Common StockJun 19, 2017P1,000$0.05A21,262,349D
Common StockJun 19, 2017P1,000$0.05A21,263,349D
Common StockJun 19, 2017P1,000$0.0514A21,264,349D
Common StockJun 19, 2017P1,000$0.0517A21,265,349D
Common StockJun 19, 2017P1,000$0.0519A21,266,349D
Common StockJun 19, 2017P1,000$0.0516A21,267,349D
Common StockJun 19, 2017P1,000$0.0517A21,268,349D
Common StockJun 19, 2017P1,000$0.052A21,269,349D

Table II — derivative securities

No Table II lines on this filing.